![Bart Geers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bart Geers
Direktor/Vorstandsmitglied bei Pulsify Medical BV
Profil
Bart Geers has worked as a Director at Pulsify Medical BV since 2019 and is currently employed there.
He also holds a Director position at Augustine Therapeutics NV, where he is currently employed.
Aktive Positionen von Bart Geers
Unternehmen | Position | Beginn |
---|---|---|
Pulsify Medical BV
![]() Pulsify Medical BV Medical SpecialtiesHealth Technology Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019. | Direktor/Vorstandsmitglied | 01.09.2019 |
Augustine Therapeutics NV
![]() Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Pulsify Medical BV
![]() Pulsify Medical BV Medical SpecialtiesHealth Technology Pulsify Medical BV is a Belgian digital medical technology company that specializes in developing wearable ultrasound patches. The company is based in Louvain, Belgium. Pulsify Medical was founded in 2019 by Lieven Herbots, Xavier Rottenberg, Jan D'hooge, Steve Stoffels. Iwan van Vijfeijken has been the CEO of the company since 2019. | Health Technology |
Augustine Therapeutics NV
![]() Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Health Services |